Power of Story Send a Tweet        

Share on Google Plus Share on Twitter 1 Share on Facebook 1 Share on LinkedIn Share on PInterest Share on Fark! Share on Reddit Share on StumbleUpon Tell A Friend 1 (3 Shares)  

Printer Friendly Page Save As Favorite View Favorites (# of views)   3 comments
General News

Outrageous Pharma/Medical Conflicts of Interest

By       Message Martha Rosenberg       (Page 1 of 4 pages)     Permalink

Related Topic(s): ; ; ; ; ; ; ; , Add Tags  Add to My Group(s)

View Ratings | Rate It

opednews.com Headlined to H2 4/17/14

Author 1353
Become a Fan
  (82 fans)
- Advertisement -

A Dean of a Medical School on a Drug Company Board ?

 

Interview About High-Level Conflicts of Interest with Walid Gellad , MD

 

- Advertisement -

Walid Gellad, MD, MPH is both assistant professor of medicine and assistant professor of health policy at the University of Pittsburgh and a physician in the US Department of Veterans Affairs (VA) Pittsburgh Healthcare System. He is coauthor of a recent research letter in the Journal of the American Medical Association (JAMA) [ Academic Medical Center Leadership on Pharmaceutical Company Boards of Directors, also by Timothy Anderson, MD, Chester Good, MD, MPH and Shravan Dave, BS] that reveals almost all US large drug companies and 40 percent of all drug companies studied have leaders in academic medical centers on their boards. These drug company board members include deans, chief executive officers, department chairs, trustees at academic medical centers, school of pharmacy officials and university presidents.

 


Serving Two Masters
(Image by Martha Rosenberg)
  Permission   Details   DMCA
- Advertisement -
 

Rosenberg:

 

Your recent JAMA paper exposes shocking industry/academic relationships many would not expect and was covered by the Associated Press, the Milwaukee-Wisconsin Journal Sentinel and a Wall Street Journal blog. What inspired you and your colleagues to investigate this?

 

Gellad:

- Advertisement -

 

There is a lot of talk right now about physician conflicts of interest, whether the discussion is about medical students accepting pens or lunches from the pharmaceutical industry or physician consulting and speaking payments becoming public with the Physician Payment Sunshine Act. Yet the issue of dual leadership--academic medical center leaders serving on pharmaceutical company boards of directors--has not really been addressed. We investigated these relationships for 2012 using publicly available data.

 

Rosenberg:

Next Page  1  |  2  |  3  |  4

 

- Advertisement -

View Ratings | Rate It

opednews.com

Martha Rosenberg is an award-winning investigative public health reporter who covers the food, drug and gun industries. Her first book, Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, is distributed by Random (more...)
 

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon Share Author on Social Media   Go To Commenting

The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
- Advertisement -

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Grassley Investigates Lilly/WebMD link Reported by Washington Post

The Drug Store in Your Tap Water

It's the Cymbalta Stupid

Are You Sure You're Not Psychotic Asks Shameless Drug Company?

Another Poorly Regulated "Derivative"--the Antidepressant Pristiq

MRSA and More. Antibiotics Linked to Obesity and Allergies, Too